SaperesteinD.S., BarohnR.J.Current concepts and controversy in chronic inflammatory demyelinating polyneuropathy. Curr Neurol Neurosci Rep2003; 3: 57–63.
3.
LunnM.P.T., ManjiH., ChoudharyP.P.Prevalence of chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in southeast England. Neurol Neurosurg Psychiatry1999; 66: 269–71.
4.
McLeodJ.G., PollardJ.D., MacaskillP., MohamedA., SpringP., KhuranaV.Prevalence of chronic inflammatory demyelinating polyneuropathy in New South Wales, Australia. Ann Neurol1999; 46: 910–3.
ChenJ., GuestS.Inflammatory demyelinating neuropathy presenting in a temporal relationship with the initiation of peritoneal dialysis. Perit Dial Int1998; 18: 542–3.
7.
LuiS.L., HuiC.K., ChanT.M., LoW.K., LaiK.N.Progressive demyelinating neuropathy after initiation of continuous ambulatory peritoneal dialysis - report of two cases. Clin Nephrol2001; 56: 407–10.
8.
AsburyA.K.Neuropathies with renal failure. In: DyckP.J., ThomasP.K., GriffinJ.W., LowP.A., PodusloJ.F., eds. Peripheral neuropathy.Philadelphia: Saunders, 1993; pp. 1251–65.
9.
RopperA.H.Accelerated neuropathy of renal failure. Arch Neurol1993; 50: 536–9.
ChanM.K., ChowL., LamS.S., JonesB.Peritoneal eosinophilia in patients on continuous ambulatory peritoneal dialysis: a prospective study. Am J Kidney Dis1988; 11: 180–3.
13.
AsgharR., WoodrowG., TurneyJ.H.A case of eosinophilic peritonitis treated with oral corticosteroids. Perit Dial Int2000; 20: 579–80.
14.
DalakasM.C.Advances in chronic inflammatory demyelinating polyneuropathy: disease variants and inflammatory response mediators and modifiers. Curr Opin Neurol1999; 12: 403–9.
15.
MatheyE.K., PollardJ.D., ArmatiP.J.TNF-α, IFN-γ and IL-2 mRNA expression in CIDP sural nerve biopsies. J Neurol Sci1999; 163: 47–52.
16.
ZamauskaiteA., Perez-CruzI., YaqoobM.M., MadrigalA., CohenS.B.Effect of renal dialysis therapy modality on T cell cytokine production. Nephrol Dial Transplant1999; 14: 49–55.
17.
MortierS., De VrieseA.S., LameireN.Recent concepts in the molecular biology of peritoneal membrane - implications for more biocompatible dialysis solutions. Blood Purif2003; 21: 14–23.
